Brandon K. Wilder

Oregon Health & Science University — United States

Medicine · Health Sciences

10h-index269citations39works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(30), Mosquito-borne diseases and control(21), Complement system in diseases(7), HIV Research and Treatment(4), Computational Drug Discovery Methods(4)

Publications39 total

IL-15 enhances T resident memory formation and function following genetically attenuated Plasmodium vaccination in mice 3232
The Journal of Immunology·2025Open Access
Addition of blood stage monoclonal antibody improves protection afforded by anti-sporozoite antibody alone in a humanized mouse model of Plasmodium falciparum malaria
2025
Development of novel Aotus nancymaae Non-human primate model for the evaluation of Plasmodium vivax blood stage vaccines and immunoprophylactics
2025Open Access
Clinical and Pathological Outcomes of Experimental Plasmodium fragile Infection in a Rhesus Macaque
American Journal of Tropical Medicine and Hygiene·2025Open Access
A 3D culture model facilitates mass production of in vitro Plasmodium falciparum haemolymph-like sporozoites
Malaria Journal·2025· 1 citedOpen Access
Identification of cross-stage, cross-species malaria CD8+ T cell antigens
2025Open Access
HaloPROTAC3 does not trigger the degradation of the halotagged parasitophorous vacuole membrane protein UIS4 during Plasmodium liver stage development
Scientific Reports·2025· 2 citedOpen Access
Generation of a Transgenic Plasmodium cynomolgi Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Testing P. vivax CSP-Based Malaria Vaccines in Non-Human Primates
Vaccines·2025Open Access
Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein
Science·2025· 14 citedOpen Access
Generation of a transgenic P <i>. cynomolgi</i> parasite expressing <i>P. vivax</i> circumsporozoite protein for testing pre-erythrocytic malaria vaccines in non-human primates
2024· 1 cited
Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages
Nature Communications·2024· 4 citedOpen Access
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype
Cell·2024· 24 citedOpen Access
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Cell·2024· 13 citedOpen Access
Review 1: "Broadly Inhibitory Antibodies against Severe Malaria Virulence Proteins"
2024Open Access
Reviews of "Broadly Inhibitory Antibodies against Severe Malaria Virulence Proteins"
2024Open Access
3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance
ACS Infectious Diseases·2024· 1 citedOpen Access
Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin
Malaria Journal·2024· 7 citedOpen Access
Using Non-Human Primate to Investigate the Generation of Liver Immunity in Malaria
The Journal of Immunology·2024
Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages
2024Open Access
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine
npj Vaccines·2024· 13 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Maya Aleshnick(16), Thomas Martinson(12), Payton Kirtley(11), Stefan H. I. Kappe(9), Ashley M. Vaughan(7), Nana Minkah(6), Sean C. Murphy(5), Martin J. Smilkstein(4), Sovitj Pou(4), Rozalia A. Dodean(4), Yuexin Li(4), Aaron Nilsen(4), Jane X. Kelly(4), Michael K. Riscoe(4), Sarah E. Silk(4), Angela M. Minassian(4), Joshua Tan(4), Kirsty McHugh(4), Simon J. Draper(4), Kristian E. Swearingen(4)